Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- 5 The androgen receptor: basic structure and function
- 6 Androgens in postmenopausal women: Their practically exclusive intracrine formation and inactivation in peripheral tissues
- 7 Diagnostic criteria of polycystic ovary syndrome
- 8 Androgen effects on the skin
- 9 Polycystic ovary syndrome and cardiovascular risk
- 10 Effects of androgens on female genital tract
- Section 3 Learning from the extremes
- Section 4 The tool kit
- Index
- Plate Section
- References
7 - Diagnostic criteria of polycystic ovary syndrome
from Section 2 - The scientific essentials
Published online by Cambridge University Press: 05 July 2015
Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- Section 2 The scientific essentials
- 5 The androgen receptor: basic structure and function
- 6 Androgens in postmenopausal women: Their practically exclusive intracrine formation and inactivation in peripheral tissues
- 7 Diagnostic criteria of polycystic ovary syndrome
- 8 Androgen effects on the skin
- 9 Polycystic ovary syndrome and cardiovascular risk
- 10 Effects of androgens on female genital tract
- Section 3 Learning from the extremes
- Section 4 The tool kit
- Index
- Plate Section
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Androgens in Gynecological Practice , pp. 74 - 78Publisher: Cambridge University PressPrint publication year: 2015
References
1.Stein, I, Leventhal, M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–185.CrossRefGoogle Scholar
2.Zawadski, JK, Dunaif, A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif, A, Givens, JR, Haseltine, FP, Merriam, GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992:377–384.Google Scholar
3.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25.Google Scholar
4.Azziz, R, Carmina, E, Dewailly, D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91(2):456–488.Google Scholar
5.Eilertsen, TB, Vanky, E, Carlsen, SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012;27(8):2494–2502.CrossRefGoogle ScholarPubMed
6.Rosenfield, RL, Wroblewski, K, Padmanabhan, V, et al. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012;98(1):242–249.CrossRefGoogle ScholarPubMed
7.Belosi, C, Selvaggi, L, Apa, R, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod 2006;21(12):3108–3115.Google Scholar
8.Fulghesu, AM, Ciampelli, M, Belosi, C, et al. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 2001;76(2):326–331.Google Scholar
9.Wild, RA, Vesely, S, Beebe, L, et al. Ferriman Gallwey Self-Scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90(7):4112–4114.Google Scholar
10.Michelmore, KF, Balen, AH, Dunger, DB, Vessey, MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999;51:779–786.CrossRefGoogle ScholarPubMed
11.March, WA, Moore, VM, Willson, KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25(2):544–551.Google Scholar
12.Yildiz, BO, Bozdag, G, Yapici, Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012;27(10):3067–3073.CrossRefGoogle ScholarPubMed
13.Mehrabian, F, Khani, B, Kelishadi, R, Ghanbari, E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Pol J Endocrinol 2011;62(3):238–242.Google Scholar
14.Knochenhauer, ES, Key, TJ, Kahsar-Miller, M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.Google Scholar
15.Azziz, R, Woods, KS, Reyna, R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–2749.Google Scholar
16.Goodarzi, MO, Quiñones, MJ, Azziz, R, et al. Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril 2005;84(3):766–769.Google Scholar
17.Moran, C, Tena, G, Moran, S, et al. Prevalence of polycystic ovary syndrome and related disorders in Mexican women. Gynecol Obstet Invest 2010;69:274–280.Google Scholar
18.Nidhi, R, Padmalatha, V, Nagarathna, R, Amritanshu, R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011;24:223–227.Google Scholar
19.Chhabra, S, Venkatraman, S. Menstrual dysfunction in rural young women and the presence of polycystic ovarian syndrome. J Obstet Gynaecol 2010;30(1):41–5.Google Scholar
20.Kumarapeli, V, Seneviratne, RA, Wijeyaratne, CN, et al. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. Am J Epidemiol 2008;168:321–328.CrossRefGoogle Scholar
21.Tehrani, FR, Rashidi, H, Azizi, F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011;9:144.CrossRefGoogle ScholarPubMed
22.Diamanti-Kandarakis, E, Kouli, CR, Bergiele, AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–4011.CrossRefGoogle ScholarPubMed
23.Boyle, JA, Cunningham, J, O’Dea, K, et al. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust 2012;196(1):62–66.Google Scholar
24.Asunción, M, Calvo, RM, San Millán, JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–2438.Google Scholar
25.DeUgarte, CM, Woods, KS, Bartolucci, AA, Azziz, R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006;91(4):1345–1350.Google Scholar
26.Zargar, AH, Wani, AI, Masoodi, SR, et al. Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent. Fertil Steril 2002;77(4):674–678.Google Scholar
27.Kelekci, KH, Kelekci, S, Incki, K, et al. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol 2010;49:775–779.Google Scholar
28.Maluki, AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol 2010;9:142–148.CrossRefGoogle ScholarPubMed
29.Wiksten-Almströmer, M, Hirschberg, AL, Hagenfeldt, K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand 2008;87:1162–1168.Google Scholar